T1	Participants 508 544	mild to moderate facial photodamage.
T2	Participants 567 628	Ten subjects (ages 35-63) with facial dyschromia and rhytides
T3	Participants 1171 1231	Ten female subjects with mild to moderate facial photodamage
T4	Participants 1370 1410	Nine of 10 patients completed the trial;
T5	Participants 2480 2498	facial photodamage
